1.Sales and profit
See section β- Rocket One Inc. lost $12.5M in fiscal 2025.
RKTO Nasdaq Pharmaceutical Preparations Financials FY2018βFY2025
Last close Β· Oct 26, 2026
$0.51
β$0.86 (β62.77%) past year
Hi! I read Rocket One Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Does it make a profit?
β$12.5M
No. It lost money last year.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Loss periods are shown in red.
KIRA summarises the numbers
Rocket One Inc. lost $12.5M in fiscal 2025.
Net income
Net income
Diluted EPS
Diluted EPS
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Dividends and buybacks
Diluted shares outstanding (annual)
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
KIRA summarises the numbers
No open-market insider trades in the last 12 months.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Rocket One Inc. can carry it.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $8.5M | $6.6M | $9.3M | $7.0M | $6.2M |
| Current ratio | 12.2x | 5.6x | 15.0x | 9.2x | 4.7x |
| Quick ratio | 12.2x | 5.6x | 15.0x | 9.2x | 4.7x |
| Total assets | $11.0M | $7.7M | $10.2M | $7.7M | $7.6M |
| Total liabilities | $1.1M | $1.6M | $0.7M | $0.8M | $1.5M |
| Shareholders' equity | $9.9M | $6.1M | $9.5M | $6.9M | $6.2M |
| Net debt (β = net cash) | β | β | β | β | β |
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Return on capital, equity and assets (annual)
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β78.0% | β165.1% | β26.4% | β27.4% | β22.1% | 3.8% | β13.5% | β34.8% |
| Altman Z'' | β60.01 | β21.53 | β7.67 | 6.87 | β18.91 | β1.57 | β18.23 | β33.06 |
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Research and development | $0.8M | $2.0M | $2.3M | $7.4M | $4.9M | $3.7M | $3.2M | $5.9M |
| Operating income | β$2.5M | β$7.7M | β$7.3M | β$14.1M | β$11.1M | β$8.0M | β$8.2M | β$12.4M |
| Pretax income | β | β | β | β | β | β | β$8.1M | β$12.4M |
| Net income | β$2.5M | β$7.7M | β$7.2M | β$14.3M | β$11.4M | β$8.1M | β$8.2M | β$12.5M |
| Net income to common | β | β | β | β$14.3M | β$11.4M | β$7.8M | β | β |
| Diluted EPS | β$0.50 | β$0.84 | β$0.58 | β$16.02 | β$9.50 | β$2.38 | β$1.28 | β$0.90 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B | 0.01B | 0.01B |
| Cash flow | ||||||||
| Cash from operations | β$2.1M | β$4.9M | β$6.1M | β$12.1M | β$9.3M | β$8.4M | β$7.0M | β$9.8M |
| Depreciation and amortization | $0.0M | $0.0M | $0.0M | β | β | β | β | β |
| Stock-based compensation | $0.1M | $2.5M | $0.7M | $1.3M | $0.6M | $0.2M | $0.8M | $1.2M |
| Balance sheet | ||||||||
| Cash and short-term investments | $0.3M | $1.7M | $2.6M | $8.5M | $6.6M | $9.3M | $7.0M | $6.2M |
| Current assets | $0.5M | $2.6M | $4.8M | $10.6M | $7.7M | $10.2M | $7.6M | $6.9M |
| Current liabilities | $0.3M | $0.4M | $0.3M | $0.9M | $1.4M | $0.7M | $0.8M | $1.5M |
| Property and equipment, net | $0.0M | $0.0M | β | β | β | β | β | β |
| Total assets | $0.5M | $2.8M | $5.2M | $11.0M | $7.7M | $10.2M | $7.7M | $7.6M |
| Total liabilities | $0.3M | $0.4M | $0.6M | $1.1M | $1.6M | $0.7M | $0.8M | $1.5M |
| Shareholders' equity | $0.2M | $2.4M | $4.6M | $9.9M | $6.1M | $9.5M | $6.9M | $6.2M |
| Returns | ||||||||
| Return on capital employed | β1,611.0% | β322.0% | β148.1% | β139.4% | β174.1% | β83.2% | β119.4% | β201.0% |
| Return on equity | β1,610.0% | β604.0% | β204.4% | β197.1% | β142.3% | β103.6% | β99.8% | β191.4% |
| Return on assets | β495.2% | β461.4% | β178.2% | β176.4% | β121.4% | β90.1% | β91.2% | β162.8% |
| Return on tangible equity | β1,610.0% | β321.6% | β154.9% | β144.5% | β186.3% | β82.3% | β119.0% | β202.7% |
| Growth | ||||||||
| Share count change | β | 82.2% | 34.9% | β92.8% | 34.1% | 184.7% | 87.0% | 116.6% |
| Financial health | ||||||||
| Current ratio | 1.4x | 6.0x | 15.3x | 12.2x | 5.6x | 15.0x | 9.2x | 4.7x |
| Quick ratio | 1.4x | 6.0x | 15.3x | 12.2x | 5.6x | 15.0x | 9.2x | 4.7x |
| Quality scores | ||||||||
| Altman Z'' | β60.0 | β21.5 | β7.7 | 6.9 | β18.9 | β1.6 | β18.2 | β33.1 |
| Accruals ratio | β78.0% | β165.1% | β26.4% | β27.4% | β22.1% | 3.8% | β13.5% | β34.8% |
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
Source: SEC EDGAR XBRL filings (CIK 0001711786). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.